Literature DB >> 20953692

Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting.

Alexandra D Müller1, Heather B Jaspan, Landon Myer, Ashley Lewis Hunter, Guy Harling, Linda-Gail Bekker, Catherine Orrell.   

Abstract

This study aims to compare the use and cost of objective and subjective measures of adherence to pediatric antiretroviral treatment in a primary care facility in South Africa. In a 1-month longitudinal study of 53 caregiver-child dyads, pharmacy refill (PR), measurement of returned syrups (RS), caregiver self-report (3DR) and Visual Analogue Scale (VAS) were compared to Medication Event Monitoring System (MEMS). Adherence was 100% for both VAS and 3DR; by PR and RS 100% and 103%, respectively. MEMS showed that 92% of prescribed doses were administered, but only 66% of these within the correct 12-hourly interval. None of the four measures correlated significantly with MEMS. MEMS data suggest that timing of doses is often more deviant from prescribed than expected and should be better addressed when monitoring adherence. Of all, MEMS was by far the most expensive measure. Alternative, cheaper electronic devices need to be more accessible in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20953692      PMCID: PMC3032912          DOI: 10.1007/s10461-010-9825-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  28 in total

1.  Compliance to combination antiretroviral therapy in HIV-1 infected children.

Authors:  S Boni; E Pontali; P De Gol; P Pedemonte; D Bassetti
Journal:  Int J Antimicrob Agents       Date:  2000-11       Impact factor: 5.283

2.  Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.

Authors:  Carol A Bova; Kristopher P Fennie; George J Knafl; Kevin D Dieckhaus; Edith Watrous; Ann B Williams
Journal:  AIDS Behav       Date:  2005-03

Review 3.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

4.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

5.  Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Côte d'Ivoire.

Authors:  Arrivé Elise; Anaky Marie France; Wemin Marie Louise; Diabate Bata; Rouet François; Salamon Roger; Msellati Philippe
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-01       Impact factor: 3.731

6.  Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs.

Authors:  R G Steele; B Anderson; B Rindel; M L Dreyer; K Perrin; R Christensen; V Tyc; P M Flynn
Journal:  AIDS Care       Date:  2001-10

7.  Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System.

Authors:  Ann E Deschamps; Veerle D E Graeve; Eric van Wijngaerden; Veerle De Saar; Anne-Mieke Vandamme; Kristien van Vaerenbergh; Helga Ceunen; Herman Bobbaers; Willy E Peetermans; Peter J de Vleeschouwer; Sabina de Geest
Journal:  AIDS Patient Care STDS       Date:  2004-11       Impact factor: 5.078

8.  Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Authors:  Russell B Van Dyke; Sophia Lee; George M Johnson; Andrew Wiznia; Kathleen Mohan; Kenneth Stanley; Edward V Morse; Paul A Krogstad; Sharon Nachman
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

9.  Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Authors:  Jessica H Oyugi; Jayne Byakika-Tusiime; Edwin D Charlebois; Cissy Kityo; Roy Mugerwa; Peter Mugyenyi; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

10.  Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.

Authors:  John Farley; Susan Hines; Amy Musk; Sherley Ferrus; Vicki Tepper
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

View more
  27 in total

1.  Patterns of HIV Treatment Adherence do not Differ Between Male and Female Adolescents in Botswana.

Authors:  Kimon L H Ioannides; Jennifer Chapman; Tafireyi Marukutira; Ontibile Tshume; Gabriel Anabwani; Robert Gross; Elizabeth D Lowenthal
Journal:  AIDS Behav       Date:  2017-02

2.  Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.

Authors:  Zachary J Tabb; Blandina T Mmbaga; Monica Gandhi; Alexander Louie; Karen Kuncze; Hideaki Okochi; Aisa M Shayo; Elizabeth L Turner; Coleen K Cunningham; Dorothy E Dow
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

3.  Patient-Reported Outcomes for Pediatric Adherence and Self-Management: A Systematic Review.

Authors:  Jill M Plevinsky; Ana M Gutierrez-Colina; Julia K Carmody; Kevin A Hommel; Lori E Crosby; Meghan E McGrady; Ahna L H Pai; Rachelle R Ramsey; Avani C Modi
Journal:  J Pediatr Psychol       Date:  2020-04-01

4.  Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa.

Authors:  Heather B Jaspan; Alexandra D Mueller; Landon Myer; Linda-Gail Bekker; Catherine Orrell
Journal:  AIDS Patient Care STDS       Date:  2011-04-06       Impact factor: 5.078

5.  Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected children.

Authors:  Rachel C Vreeman; Winstone M Nyandiko; Hai Liu; Wanzhu Tu; Michael L Scanlon; James E Slaven; Samuel O Ayaya; Thomas S Inui
Journal:  AIDS Behav       Date:  2015-04

6.  Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women.

Authors:  Jose R Castillo-Mancilla; Kristina Searls; Patricia Caraway; Jia-Hua Zheng; Edward M Gardner; Julie Predhomme; Lane R Bushman; Peter L Anderson; Amie L Meditz
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-20       Impact factor: 2.205

7.  Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.

Authors:  Chloe A Teasdale; Elaine J Abrams; Ashraf Coovadia; Renate Strehlau; Leigh Martens; Louise Kuhn
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

8.  Assessing Adherence to Antiretroviral Therapy in a Rural Paediatric Cohort in KwaZulu-Natal, South Africa.

Authors:  Chanelle Smith; Tanuja N Gengiah; Nonhlanhla Yende-Zuma; Michele Upfold; Kogieleum Naidoo
Journal:  AIDS Behav       Date:  2016-11

9.  Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya.

Authors:  Matthew D Hickey; Charles R Salmen; Robert A Tessler; Dan Omollo; Peter Bacchetti; Richard Magerenge; Brian Mattah; Marcus R Salmen; Daniel Zoughbie; Kathryn J Fiorella; Elvin Geng; Betty Njoroge; Chengshi Jin; Yong Huang; Elizabeth A Bukusi; Craig R Cohen; Monica Gandhi
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

10.  Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe.

Authors:  Bernard Ngara; Simbarashe Zvada; Tariro Dianah Chawana; Charles Fungai Brian Nhachi; Simbarashe Rusakaniko
Journal:  BMC Pharmacol Toxicol       Date:  2021-05-24       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.